Instrument Inactif

Communiqués Intersect ENT, Inc.

Actions

XENT

US46071F1030

Equipement, fournitures et distribution médicale

Communiqués

13/05/22	INTERSECT ENT, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
09/05/22	INTERSECT ENT, INC. : Other Events (form 8-K)	AQ
04/05/22	INTERSECT ENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
18/04/22	INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
23/03/22	INTERSECT ENT, INC. : Other Events (form 8-K)	AQ
08/03/22	INTERSECT ENT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
25/01/22	Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization	BU
02/11/21	Intersect ENT: Q3 Earnings Snapshot	AQ
02/11/21	INTERSECT ENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
02/11/21	Intersect ENT Reports Third Quarter 2021 Financial Results - Form 8-K	PU
02/11/21	Intersect ENT Reports Third Quarter 2021 Financial Results	BU
28/10/21	First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe	BU
08/10/21	INTERSECT ENT, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
27/09/21	INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
27/09/21	Intersect ENT : Supplemental Disclosures to the Proxy Statement (Form 8-K)	PU
27/09/21	INTERSECT ENT, INC. : Other Events (form 8-K)	AQ
20/09/21	Intersect ENT : Understanding the Difference between COVID-19 Symptoms and Sinus Disease World Sinus Health Awareness Day 2021	PU
16/08/21	INTERSECT ENT, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
10/08/21	Intersect ENT : PROJECT KRAKEN MERGER SUB, INC. AND (Form 8-K)	PU
10/08/21	INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
07/08/21	INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT	BU
06/08/21	INTERSECT ENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/08/21	Intersect ENT: Q2 Earnings Snapshot	AQ
06/08/21	Intersect ENT : Reports Second Quarter 2021 Financial Results	BU
06/08/21	INTERSECT ENT, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ